The present stock price for Corvus Pharmaceuticals Inc. (CRVS) is $3.08. In the last trading session, the stock made a considerable jump, reaching $3.3699 after an opening price of $3.33. The stock briefly fell to $3.02 before ending the session at $3.37.
In terms of market performance, Corvus Pharmaceuticals Inc. had a fairly even. The highest value for the stock in the past year was $3.70 on 05/18/23, and the lowest value was recorded at $0.61 on 03/28/23.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
52-week price history of CRVS Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Corvus Pharmaceuticals Inc.’s current trading price is -16.76% away from its 52-week high, while its distance from the 52-week low is 407.41%. The stock’s price range during this period has spanned from $0.61 to $3.70. In the Healthcare sector, the Corvus Pharmaceuticals Inc.’s shares surpassed a trading volume of approximately 0.85 million for the day, which was noticeably higher compared to the average daily volume of 9.0.73 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Corvus Pharmaceuticals Inc. (CRVS) has experienced a quarterly rise of 289.92% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 146.08M and boasts a workforce of 29 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.06, with a change in price of +2.29. Similarly, Corvus Pharmaceuticals Inc. recorded 498,136 in trading volume during the last 100 days, posting a change of +291.81%.
Examining CRVS’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for CRVS stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
CRVS Stock Stochastic Average
Today’s raw stochastic average for Corvus Pharmaceuticals Inc. over the last 50 days is 79.95%.This indicates a increase from the raw stochastic average of the past 20 days, which was 77.20%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 82.11% and 84.61%, respectively.
CRVS Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The index has shown a price gain of 262.35% this year. Over the last six months, there has been a weaker performance of 238.46%. The price of CRVS fallen by 208.00% during the last 30 days period. For the last 5-days stocks have improved 29.96%.